These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22539249)

  • 21. Fulminant chemical ventriculomeningitis following intrathecal liposomal cytarabine administration.
    Butto A; Al-Holou WN; Junck L; Sagher O; Fletcher JJ
    J Clin Neurosci; 2011 Oct; 18(10):1417-8. PubMed ID: 21764318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-Hodgkin's lymphoma and the CNS: prophylaxis and therapy in immunocompetent and HIV-positive individuals.
    Mazhar D; Stebbing J; Bower M
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):335-41. PubMed ID: 16503851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and Efficacy of Liposomal Cytarabine in the Treatment of Neoplastic Meningitis.
    Jahn F; Jordan K; Behlendorf T; Globig C; Schmoll HJ; Müller-Tidow C; Jordan B
    Oncology; 2015; 89(3):137-42. PubMed ID: 25791073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and tolerability of intrathecal liposomal cytarabine as central nervous system prophylaxis in patients with acute lymphoblastic leukemia.
    Valentin A; Troppan K; Pfeilstöcker M; Nösslinger T; Linkesch W; Neumeister P
    Leuk Lymphoma; 2014 Aug; 55(8):1739-42. PubMed ID: 24138308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flushing out of cerebrospinal fluid as a therapy for acute cerebellar dysfunction caused by high dose of cytosine arabinoside: a case report.
    Pellier I; Leboucher B; Rachieru P; Ifrah N; Rialland X
    J Pediatr Hematol Oncol; 2006 Dec; 28(12):837-9. PubMed ID: 17164656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurologic complications of intrathecal liposomal cytarabine administered prophylactically to patients with non-Hodgkin lymphoma.
    Gállego Pérez-Larraya J; Palma JA; Carmona-Iragui M; Fernández-Torrón R; Irimia P; Rodríguez-Otero P; Panizo C; Martínez-Vila E
    J Neurooncol; 2011 Jul; 103(3):603-9. PubMed ID: 20953897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrathecal liposomal cytarabine for treatment of leptomeningeal involvement in transformed (Richter's syndrome) and non-transformed B-cell chronic lymphocytic leukaemia in Spain: a report of seven cases.
    Calvo-Villas JM; Fernández JA; de la Fuente I; Godoy AC; Mateos MC; Poderós C
    Br J Haematol; 2010 Sep; 150(5):618-20. PubMed ID: 20487439
    [No Abstract]   [Full Text] [Related]  

  • 28. Liposomal cytarabine in cerebrospinal fluid.
    Boyd K; Jenner M; Treleaven J; Kenny J; Rhoades E
    Br J Haematol; 2009 Jun; 145(6):679. PubMed ID: 19076172
    [No Abstract]   [Full Text] [Related]  

  • 29. Intrathecal depot cytarabine therapy: a welcome addition to a limited armamentarium.
    Bleyer WA
    Clin Cancer Res; 1999 Nov; 5(11):3349-51. PubMed ID: 10589743
    [No Abstract]   [Full Text] [Related]  

  • 30. Liposomal cytarabine in prophylaxis or curative treatment of central nervous system involvement in Burkitt leukemia/lymphoma.
    Segot A; Raffoux E; Lengline E; Thieblemont C; Dombret H; Boissel N; Cluzeau T
    Ann Hematol; 2015 Nov; 94(11):1859-63. PubMed ID: 26280395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of intrathecal liposomal cytarabine for the treatment of meningeal relapse in acute lymphoblastic leukemia: experience of two pediatric institutions.
    Parasole R; Menna G; Marra N; Petruzziello F; Locatelli F; Mangione A; Misuraca A; Buffardi S; Di Cesare-Merlone A; Poggi V
    Leuk Lymphoma; 2008 Aug; 49(8):1553-9. PubMed ID: 18766969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compassionate use of intrathecal depot liposomal cytarabine as treatment of central nervous system involvement in acute leukemia: report of 6 cases.
    Sancho JM; Ribera JM; Romero MJ; Martín-Reina V; Giraldo P; Ruiz E
    Haematologica; 2006 Mar; 91(3):ECR02. PubMed ID: 16533729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of lymphomatous and leukemic meningitis with liposomal encapsulated cytarabine.
    Kripp M; Hofheinz RD
    Int J Nanomedicine; 2008; 3(4):397-401. PubMed ID: 19337408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis: efficacy and long-term safety in a single institution.
    Brion A; Legrand F; Larosa F; Schillinger F; Garnache-Ottou F; Helias P; Fontan J; Heczko M; Delaby P; Daguindau E; Vuillier J; Chauchet A; Deconinck E
    Invest New Drugs; 2012 Aug; 30(4):1697-702. PubMed ID: 21229289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hematologic tumors].
    Ogawa M
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1416-21. PubMed ID: 14584273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New liposomal cytarabine formulation in CSF.
    Casado P; Torreira C; Oujo E; Esteban P; Albo C; Diaz R; Andrade MA
    Clin Lab; 2010; 56(1-2):69-70. PubMed ID: 20380362
    [No Abstract]   [Full Text] [Related]  

  • 37. "Flushing out" cytosine arabinoside from CSF to reverse neurotoxicity.
    Bleyer A
    J Pediatr Hematol Oncol; 2007 Apr; 29(4):274. PubMed ID: 17414574
    [No Abstract]   [Full Text] [Related]  

  • 38. Side effects of intermediate- and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute leukaemia and non-Hodgkin's lymphoma.
    Peters WG; Willemze R; Colly LP; Guiot HF
    Neth J Med; 1987 Feb; 30(1-2):64-74. PubMed ID: 3473310
    [No Abstract]   [Full Text] [Related]  

  • 39. Liposomal cytarabine (DepoCyte) for the treatment of neoplastic meningitis.
    Rueda Domínguez A; Olmos Hidalgo D; Viciana Garrido R; Torres Sánchez E
    Clin Transl Oncol; 2005 Jul; 7(6):232-8. PubMed ID: 16131445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy and safety of induction chemotherapy consisting of anthracycline for 3 days and cytarabine for 7 days in elderly patients with acute myeloid leukemia].
    Kurahashi S; Iwasaki T; Suzuki H; Sawamoto A; Sugimoto T; Narimatsu H; Adachi T; Hayakawa F; Sugiura I
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1617-21. PubMed ID: 17940376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.